Innovation, Excellence, Progress Research and Development
about ourLaboratory
Laboratories used for scientific research take many forms, each designed to meet specific requirements. At BhiPerformance, a division of BHI Therapeutic Sciences, we are committed to excellence in every step of our process. We manufacture all our products using the highest quality, clinical-grade, or GMP-certified reagents, ensuring they meet stringent standards for clinical use. With over a decade of expertise, our team of dedicated scientists has been at the forefront of Wharton’s Jelly-derived Mesenchymal Stem Cell (WJ-MSC) research, perfecting innovative solutions to support advanced therapeutic applications. Our unwavering focus on quality and innovation drives our mission to deliver transformative outcomes.
ourResearch
We take pride in leading the field with the only long-term safety study published in U.S. peer-reviewed literature for Wharton’s Jelly-derived Mesenchymal Stem Cell (WJ-MSC) therapies. Our index patient, tracked since 2017, has shown no significant side effects, underscoring the safety and efficacy of our approach. This milestone reflects our unwavering commitment to advancing regenerative medicine through rigorous research and evidence-based practices.
meticulously craftedstem cells
The BhiPerformance team, led by Brian Mehling, M.D., oversees every step of our meticulous operation in our state-of-the-art laboratory, equipped with the latest technology to ensure the highest standards of quality and safety. From obtaining informed consent from donors to cord procurement, processing, and culturing, every aspect is handled with precision. Our process culminates in the final harvest of Wharton’s Jelly-derived Mesenchymal Stem Cells (WJ-MSCs). This comprehensive approach, powered by cutting-edge technology, reflects our dedication to delivering advanced regenerative solutions backed by scientific excellence and ethical practices.